Zhang et al. performed a meta-analysis that involved 17 studies with a total of 2047 patients and analyzed the relationship between the number of copies of the EGFR gene and the response to treatment with EGFR-TKI in patients with advanced NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.